The impairment of ILK related angiogenesis involved in cardiac maladaptation after infarction

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Xie, Jun ^a   Lu, Wen ^a   Gu, Rong ^a   Dai, Qin ^a   Zong, Bin ^a   Ling, Lin ^a   Xu, Biao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTEGRIN LINKED KINASE; MESSENGER RNA; VASCULOTROPIN; INTEGRIN-LINKED KINASE; NOS3 PROTEIN, RAT; PROTEIN SERINE THREONINE KINASE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DOWN REGULATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; MICROVASCULATURE; MUSCLE CELL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE THERAPY; GENETICS; HEART; HEART MUSCLE; HEART VENTRICLE REMODELING; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING;

RATTUS;

ANIMALS; BLOTTING, WESTERN; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE THERAPY; HEART; MALE; MICROVESSELS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 80052829997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024115     Document Type: Article

References (26)

1. Hill JA, Olson EN, (2008) Cardiac plasticity. N Engl J Med 358: 1370-1380.
2. Sano M, Schneider MD, (2002) Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload. Circulation 105: 8-10.
3. Gerdes AM, Kellerman SE, Moore JA, Muffly KE, Clark LC, et al. (1992) Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86: 426-430.
4. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, et al. (2006) Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47: 887-893.
5. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, et al. (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446: 444-448.
6. Legate KR, Montanez E, Kudlacek O, Fassler R, (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7: 20-31.
7. Hannigan GE, Coles JG, Dedhar S, (2007) Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ Res 100: 1408-1414.
8. Lu H, Fedak PW, Dai X, Du C, Zhou YQ, et al. (2006) Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation 114: 2271-2279.
9. Friedrich EB, Liu E, Sinha S, Cook S, Milstone DS, et al. (2004) Integrin-linked kinase regulates endothelial cell survival and vascular development. Mol Cell Biol 24: 8134-8144.
10. Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, et al. (2004) Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5: 79-90.
11. Ding L, Dong L, Chen X, Zhang L, Xu X, et al. (2009) Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation 120: 764-773.
12. Shi Z, Chen AD, Xu Y, Chen Q, Gao XY, et al. (2009) Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats. Pflugers Arch 458: 247-257.
13. Jiang D, Liang J, Campanella GS, Guo R, Yu S, et al. (2010) Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest 120: 2049-2057.
14. Ferrara N, (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543.
15. Razeghi P, Wang ME, Youker KA, Golfman L, Stepkowski S, et al. (2007) Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart. Cardiovasc Res 74: 133-139.
16. Westenbrink BD, Ruifrok WP, Voors AA, Tilton RG, van Veldhuisen DJ, et al. (2010) Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res.
17. Lipsic E, Westenbrink BD, van der Meer P, van der Harst P, Voors AA, et al. (2008) Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit. Eur J Heart Fail 10: 22-29.
18. Yndestad A, Landro L, Ueland T, Dahl CP, Flo TH, et al. (2009) Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J 30: 1229-1236.
19. Anversa P, Beghi C, Kikkawa Y, Olivetti G, (1986) Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 58: 26-37.
20. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, et al. (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108-2118.
21. Shimano M, Ouchi N, Shibata R, Ohashi K, Pimentel DR, et al. (2010) Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. J Mol Cell Cardiol.
22. Heba G, Krzeminski T, Porc M, Grzyb J, Ratajska A, et al. (2001) The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats. J Vasc Res 38: 288-300.
23. Oostendorp M, Douma K, Wagenaar A, Slenter JM, Hackeng TM, et al. (2010) Molecular magnetic resonance imaging of myocardial angiogenesis after acute myocardial infarction. Circulation 121: 775-783.
24. Amaravadi R, Thompson CB, (2005) The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115: 2618-2624.
25. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
26. Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, et al. (2001) Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103: 670-677.